Abstract:Juan-Juan Cheng, 1 Xing-Dong Ma, 1 Gao-Xiang Ai, 1 Qiu-Xia Yu, 2 Xiao-Ying Chen, 1 Fang Yan, 3, 4 Yu-Cui Li, 1 Jian-Hui Xie, 3, 5, 6 Zi-Ren Su, 1 Qing-Feng Xie 3, 4 1 School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, 510006, People's Republic of China; 2 The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510120, People's Republic of China; 3 The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, People's Republic of China; 4 Li Ke and Qi Yu-ru Academic Experience Inheritance Studio, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510006, People's Republic of China; 5 State Key Laboratory of Dampness Syndrome of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, People's Republic of China; 6 Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, 510120, People's Republic of China Correspondence: Qing-Feng Xie; Zi-Ren Su, Email ; Purpose: Gouty arthritis could be triggered by the deposition of monosodium uric acid (MSU) crystals. Palmatine (PAL), a protoberberine alkaloid, has been proven to possess compelling health-beneficial activities. In this study, we aimed to explore the effect of PAL on LPS plus MSU crystal-stimulated gouty arthritis in vitro and in vivo. Methods: PMA-differentiated THP-1 macrophages were primed with LPS and then stimulated with MSU crystal in the presence or absence of PAL. The expression of pro-inflammatory cytokines and oxidative stress-related biomarkers and signal pathway key targets were determined by ELISA kit, Western blot, immunohistochemistry and qRT-PCR, respectively. In addition, the anti-inflammatory and antioxidant activities of PAL on MSU-induced arthritis mice were also evaluated. Results: The results indicated that PAL (20, 40 and 80 μM) dose-dependently decreased the mRNA expression and levels of pro-inflammatory cytokines (interleukin-1beta (IL-1β), IL-6, IL-18 and tumor necrosis factor alpha (TNF-α)). The levels of superoxide dismutase (SOD) and glutathione (GSH) were remarkably enhanced, while the level of malondialdehyde (MDA) was reduced. Western blot analysis revealed that PAL appreciably inhibited NF-κB/NLRP3 signaling pathways through inhibiting the phosphorylation of p-65 and IκBα, blocking the expression of NLRP3, ASC, IL-1β and Caspase-1, as well as enhancing the antioxidant protein expression of Nrf2 and HO-1. In vivo, PAL attenuated MSU-induced inflammation in gouty arthritis, as evidenced by mitigating the joint swelling, and decreasing the productions of IL-1β, IL-6, IL-18, TNF-α and MDA, while enhancing the levels of SOD and GSH. Moreover, PAL further attenuated the infiltration of neutrophils into joint synovitis. Conclusion: PAL protected against MSU-induced inflammation and oxidative stress via regulating the NF-κB/NLRP3 and Nrf2 pathways. PAL may represent a potential candidate for the treatment of gouty arthritis. Keywords: palmatine, NF-κB/Nrf2 signal pathways, NLRP3 inflammasome, gouty arthritis In recent years, gouty arthritis or gout is one of the most common metabolic diseases. The number of gouty patients is gradually increasing with the aging of the population and the change in lifestyle, especially men and postmenopausal women. 1 They usually exhibit extreme pain, erythema, redness and joint swelling. 2 If the joint is not treated in time, it will become stiff and deformed, which could seriously increase their financial burden, affect their quality of life and may even lead to incapacity of action. 3 The hallmark for the diagnosis of this disorder is the precipitation of monosodium urate (MSU) crystals in the joint or periarticular tissues. 4 NLRP3 inflammasome has received particular attention in the development of MSU-induced gout arthritis. 4 It is composed of NLRP3, apoptosis-associated speck-like protein containing a CARD (ASC), and pro-caspase-1. 5 The activation of NLRP3 inflammasome requires a two-step process. 6 The first priming signal is that lipopolysaccharide (LPS) activates nuclear factor-κB (NF-κB) signal pathway, which promotes the expression of inflammasome components, such as NLRP3 and pro‐IL‐1β. 7 The second activation signal is that monosodium urate (MSU) crystals are taken up by macrophages, which promotes the assembly and activation of the NLRP3 inflammasome. 5 Furthermore, MSU-induced gouty inflammation was -Abstract Truncated-

Palmatine ameliorates N-methyl-N'-nitrosoguanidine-induced chronic atrophic gastritis through the STAT1/CXCL10 axis

Palmatine ameliorates Helicobacter pylori-induced chronic atrophic gastritis by inhibiting MMP-10 through ADAM17/EGFR

Astragalus Polysaccharide Inhibits Apoptosis and Inflammation to Alleviate Chronic Atrophic Gastritis Through NF-κB Signaling Pathway in Rats

UPLC-Q-TOF/MS-Based Serum and Urine Metabonomics Study on the Ameliorative Effects of Palmatine on Helicobacter pylori–Induced Chronic Atrophic Gastritis

Palmatine inhibits expression fat mass and obesity associated protein (FTO) and exhibits a curative effect in dextran sulfate sodium (DSS)-induced experimental colitis

Palmatine alleviates inflammation and modulates ferroptosis against dextran sulfate sodium (DSS)-induced ulcerative colitis

Palmatine from Mahonia bealei attenuates gut tumorigenesis in ApcMin/+ mice via inhibition of inflammatory cytokines

Palmatine Ameliorates Motor Deficits and Dopaminergic Neuron Loss by Regulating NLRP3 Inflammasome through Mitophagy in Parkinson's Disease Model Mice

Chondroprotective Effects of Palmatine on Osteoarthritis in Vivo and in Vitro: A Possible Mechanism of Inhibiting the Wnt/β-catenin and Hedgehog Signaling Pathways.

Palmatine protects against atherosclerosis by gut microbiota and phenylalanine metabolism

Bergenin, Acting as an Agonist of PPARγ, Ameliorates Experimental Colitis in Mice through Improving Expression of SIRT1, and Therefore Inhibiting NF-κB-Mediated Macrophage Activation

Costunolide ameliorates MNNG-induced chronic atrophic gastritis through inhibiting oxidative stress and DNA damage via activation of Nrf2

The mechanism of folic acid on N-methyl-N’-nitro-N-nitrosoguanidine-induced chronic atrophic gastritis through the PI3K/Akt pathway.

Morphological and Pathologic Changes of Experimental Chronic Atrophic Gastritis (CAG) and the Regulating Mechanism of Protein Expression in Rats

Muscovite Reverses Gastric Gland Atrophy and Intestinal Metaplasia by Promoting Cell Proliferation in Rats with Atrophic Gastritis.

Epiberberine ameliorates MNNG-induced chronic atrophic gastritis by acting on the EGFR-IL33 axis

Palmatine reverse aristolochic acid-induced heart failure through activating EGFR pathway via upregulating IKBKB

Rutaecarpine Ameliorates Murine N-Methyl-N’-Nitro-N-Nitrosoguanidine-Induced Chronic Atrophic Gastritis by Sonic Hedgehog Pathway

Palmatine Protects Against MSU-Induced Gouty Arthritis via Regulating the NF-κB/NLRP3 and Nrf2 Pathways

Effects of Rutaecarpine on Chronic Atrophic Gastritis Through Nucleotide-binding Oligomerization Domain-like Receptors and Inflammasomes

Berberine Attenuates Chronic Atrophic Gastritis Induced by MNNG and Its Potential Mechanism